Evaluation of long-term efficacy of interferon alpha-2b and ribavirin in combination in naive patients with chronic hepatitis C: an Italian multicenter experience

This publication has 18 references indexed in Scilit:

• Interferon alpha-2b and ribavirin in combination for patients with chronic hepatitis C who failed to respond to, or relapsed after, interferon alpha therapy: a randomized trial
  The American Journal of Medicine, 1999
• Interferon-α-2B and ribavirin in combination for chronic hepatitis C patients not responding to interferon-α alone: an italian multicenter, randomized, controlled, clinical study
  American Journal of Gastroenterology, 1998
• Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis C
  New England Journal of Medicine, 1998
• Interferon Alfa-2b Alone or in Combination with Ribavirin for the Treatment of Relapse of Chronic Hepatitis C
  New England Journal of Medicine, 1998
• Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus
  Published by Elsevier ,1998
• Randomised, double-blind, placebo-controlled trial of interferon α-2b with and without ribavirin for chronic hepatitis C
  The Lancet, 1998
• Therapy of hepatitis C: Meta-analysis of interferon alfa-2b trials
  Hepatology, 1997
• Hepatitis C viral RNA titers in serum prior to, during, and after oral treatment with ribavirin for chronic hepatitis C
  Journal of Medical Virology, 1993
• A Pilot Study of Ribavirin Therapy for Chronic Hepatitis C
  Hepatology, 1992
• Ribavirin treatment for chronic hepatitis C
  The Lancet, 1991